Broadcast and social media ads for Zepbound and Mounjaro are false because they cite outdated clinical trials that compare the highest doses of Lilly’s medicines to lower doses of Novo’s Wegovy and Ozempic, the lawsuit states.
Broadcast and social media ads for Zepbound and Mounjaro are false because they cite outdated clinical trials that compare the highest doses of Lilly’s medicines to lower doses of Novo’s Wegovy and Ozempic, the lawsuit states.